An expanded analysis framework for multivariate GWAS connects inflammatory biomarkers to functional variants and disease

Sanni Ruotsalainen(University of Helsinki), Jaakko Kaprio(University of Helsinki), Dawn Waterworth(GlaxoSmithKline (United States)), Anne Pitkäranta, Urho M. Kujala(University of Jyväskylä), Jake Lin(University of Helsinki), Jukka Partanen(Finnish Red Cross), Anna Cichońska(Harmonic Drive (Germany)), Juulia Partanen(Institute for Molecular Medicine Finland), Minna Hendolin(AbbVie (United States)), Ida Surakka(University of Helsinki), Anders Mälarstig(Karolinska Institutet), Kimmo Savinainen(Tampere University), Bridget Riley‐Gillis(AbbVie (United States)), Tomi P. Mäkelä(University of Helsinki), Raimo Pakkanen, Kari Pulkki(University of Eastern Finland), Christian Benner, Riitta Kaarteenaho(Oulu University Hospital), Outi Tuovila, Mark I. McCarthy(Centre for Human Genetics), Howard J. Jacob(Medical College of Wisconsin), Terhi Kilpi(Finnish Institute for Health and Welfare), Jeff Waring(University of Helsinki), Heiko Runz(Heidelberg University), Robert M. Plenge, Mark J. Daly(Broad Institute), Meg Ehm(Merck & Co., Inc., Rahway, NJ, USA (United States)), Julie Hunkapiller, Veli‐Matti Kosma(University of Eastern Finland), Sally John, Kathy Call(University of Helsinki), Petri Virolainen
European Journal of Human Genetics
October 27, 2020
Cited by 29


Related Papers